In a melanoma mouse model generated by injecting the A375 melanoma cell line, treatment with TanCAR-T cells led to a more pronounced reduction in tumor burden compared to controls and the single-target CAR (CD70 or B7-H3) groups. Here, CD276 is linked to melanoma.